Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

SUMMARY: Limited data exist on the efficacy of long-term therapies for osteoporosis. In osteoporotic postmenopausal women receiving denosumab for 7 years, nonvertebral fracture rates significantly decreased in years 4–7 versus years 1–3. This is the first demonstration of a further benefit on fractu...

詳細記述

保存先:
書誌詳細
出版年:Osteoporos Int
主要な著者: Ferrari, S., Adachi, J. D., Lippuner, K., Zapalowski, C., Miller, P. D., Reginster, J.-Y., Törring, O., Kendler, D. L., Daizadeh, N. S., Wang, A., O’Malley, C. D., Wagman, R. B., Libanati, C., Lewiecki, E. M.
フォーマット: Artigo
言語:Inglês
出版事項: Springer London 2015
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656715/
https://ncbi.nlm.nih.gov/pubmed/26068295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-015-3179-x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料